Selected research
Industry Research
Immune Gummies Industry Research Report 2026
Market perspective
The global Immune Gummies market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Immune Gummies is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Immune Gummies is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Immune Gummies is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Immune Gummies include Pfizer Inc, Schiff Vitamins, OLLY Public Benefit Corporation, Alani Nu, Windmill Health Products, Nature's Way Products, Chapter One, Hims, Inc and Sambucol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Immune Gummies market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Immune Gummies Market by Company
Pfizer Inc
Schiff Vitamins
OLLY Public Benefit Corporation
Alani Nu
Windmill Health Products
Nature's Way Products
Chapter One
Hims, Inc
Sambucol
Jamieson
Blackmores
GNC Holdings
Immune Gummies Segment by Type
60-count
120-count
Other
Immune Gummies Segment by Application
Online Shopping
Retailers
Supermarket
Other
Immune Gummies Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immune Gummies market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Immune Gummies and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immune Gummies.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Immune Gummies manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Immune Gummies by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Immune Gummies in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 60-count
- 120-count
- Other
Applications
- Online Shopping
- Retailers
- Supermarket
- Other
Companies covered
- Pfizer Inc
- Schiff Vitamins
- OLLY Public Benefit Corporation
- Alani Nu
- Windmill Health Products
- Nature's Way Products
- Chapter One
- Hims, Inc
- Sambucol
- Jamieson
- Blackmores
- GNC Holdings
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Immune Gummies Market Size (2021-2032)
- 2.2.2 Global Immune Gummies Sales (2021-2032)
- 2.2.3 Global Immune Gummies Market Average Price (2021-2032)
- 2.3 Immune Gummies by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 60-count
- 2.3.3 120-count
- 2.3.4 Other
- 2.4 Immune Gummies by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Online Shopping
- 2.4.3 Retailers
- 2.4.4 Supermarket
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Immune Gummies Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Immune Gummies Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Immune Gummies Revenue of Manufacturers (2021-2026)
- 3.4 Global Immune Gummies Average Price by Manufacturers (2021-2026)
- 3.5 Global Immune Gummies Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Immune Gummies, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Immune Gummies, Product Type & Application
- 3.8 Global Manufacturers of Immune Gummies, Established Date
- 3.9 Global Immune Gummies Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pfizer Inc
- 4.1.1 Pfizer Inc Company Information
- 4.1.2 Pfizer Inc Business Overview
- 4.1.3 Pfizer Inc Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pfizer Inc Immune Gummies Product Portfolio
- 4.1.5 Pfizer Inc Recent Developments
- 4.2 Schiff Vitamins
- 4.2.1 Schiff Vitamins Company Information
- 4.2.2 Schiff Vitamins Business Overview
- 4.2.3 Schiff Vitamins Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Schiff Vitamins Immune Gummies Product Portfolio
- 4.2.5 Schiff Vitamins Recent Developments
- 4.3 OLLY Public Benefit Corporation
- 4.3.1 OLLY Public Benefit Corporation Company Information
- 4.3.2 OLLY Public Benefit Corporation Business Overview
- 4.3.3 OLLY Public Benefit Corporation Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 OLLY Public Benefit Corporation Immune Gummies Product Portfolio
- 4.3.5 OLLY Public Benefit Corporation Recent Developments
- 4.4 Alani Nu
- 4.4.1 Alani Nu Company Information
- 4.4.2 Alani Nu Business Overview
- 4.4.3 Alani Nu Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Alani Nu Immune Gummies Product Portfolio
- 4.4.5 Alani Nu Recent Developments
- 4.5 Windmill Health Products
- 4.5.1 Windmill Health Products Company Information
- 4.5.2 Windmill Health Products Business Overview
- 4.5.3 Windmill Health Products Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Windmill Health Products Immune Gummies Product Portfolio
- 4.5.5 Windmill Health Products Recent Developments
- 4.6 Nature's Way Products
- 4.6.1 Nature's Way Products Company Information
- 4.6.2 Nature's Way Products Business Overview
- 4.6.3 Nature's Way Products Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Nature's Way Products Immune Gummies Product Portfolio
- 4.6.5 Nature's Way Products Recent Developments
- 4.7 Chapter One
- 4.7.1 Chapter One Company Information
- 4.7.2 Chapter One Business Overview
- 4.7.3 Chapter One Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Chapter One Immune Gummies Product Portfolio
- 4.7.5 Chapter One Recent Developments
- 4.8 Hims, Inc
- 4.8.1 Hims, Inc Company Information
- 4.8.2 Hims, Inc Business Overview
- 4.8.3 Hims, Inc Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hims, Inc Immune Gummies Product Portfolio
- 4.8.5 Hims, Inc Recent Developments
- 4.9 Sambucol
- 4.9.1 Sambucol Company Information
- 4.9.2 Sambucol Business Overview
- 4.9.3 Sambucol Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sambucol Immune Gummies Product Portfolio
- 4.9.5 Sambucol Recent Developments
- 4.10 Jamieson
- 4.10.1 Jamieson Company Information
- 4.10.2 Jamieson Business Overview
- 4.10.3 Jamieson Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Jamieson Immune Gummies Product Portfolio
- 4.10.5 Jamieson Recent Developments
- 4.11 Blackmores
- 4.11.1 Blackmores Company Information
- 4.11.2 Blackmores Business Overview
- 4.11.3 Blackmores Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Blackmores Immune Gummies Product Portfolio
- 4.11.5 Blackmores Recent Developments
- 4.12 GNC Holdings
- 4.12.1 GNC Holdings Company Information
- 4.12.2 GNC Holdings Business Overview
- 4.12.3 GNC Holdings Immune Gummies Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 GNC Holdings Immune Gummies Product Portfolio
- 4.12.5 GNC Holdings Recent Developments
5 Global Immune Gummies Market Scenario by Region
- 5.1 Global Immune Gummies Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Immune Gummies Sales by Region: 2021-2032
- 5.2.1 Global Immune Gummies Sales by Region: 2021-2026
- 5.2.2 Global Immune Gummies Sales by Region: 2027-2032
- 5.3 Global Immune Gummies Revenue by Region: 2021-2032
- 5.3.1 Global Immune Gummies Revenue by Region: 2021-2026
- 5.3.2 Global Immune Gummies Revenue by Region: 2027-2032
- 5.4 North America Immune Gummies Market Facts & Figures by Country
- 5.4.1 North America Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Immune Gummies Sales by Country (2021-2032)
- 5.4.3 North America Immune Gummies Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Immune Gummies Market Facts & Figures by Country
- 5.5.1 Europe Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Immune Gummies Sales by Country (2021-2032)
- 5.5.3 Europe Immune Gummies Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Immune Gummies Market Facts & Figures by Country
- 5.6.1 Asia Pacific Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Immune Gummies Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Immune Gummies Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Immune Gummies Market Facts & Figures by Country
- 5.7.1 South America Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Immune Gummies Sales by Country (2021-2032)
- 5.7.3 South America Immune Gummies Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Immune Gummies Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Immune Gummies Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Immune Gummies Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Immune Gummies Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Immune Gummies Sales by Type (2021-2032)
- 6.1.1 Global Immune Gummies Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Immune Gummies Sales Market Share by Type (2021-2032)
- 6.2 Global Immune Gummies Revenue by Type (2021-2032)
- 6.2.1 Global Immune Gummies Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Immune Gummies Revenue Market Share by Type (2021-2032)
- 6.3 Global Immune Gummies Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Immune Gummies Sales by Application (2021-2032)
- 7.1.1 Global Immune Gummies Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Immune Gummies Sales Market Share by Application (2021-2032)
- 7.2 Global Immune Gummies Revenue by Application (2021-2032)
- 7.2.1 Global Immune Gummies Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Immune Gummies Revenue Market Share by Application (2021-2032)
- 7.3 Global Immune Gummies Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Immune Gummies Value Chain Analysis
- 8.1.1 Immune Gummies Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Immune Gummies Production Mode & Process
- 8.2 Immune Gummies Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Immune Gummies Distributors
- 8.2.3 Immune Gummies Customers
9 Global Immune Gummies Analyzing Market Dynamics
- 9.1 Immune Gummies Industry Trends
- 9.2 Immune Gummies Industry Drivers
- 9.3 Immune Gummies Industry Opportunities and Challenges
- 9.4 Immune Gummies Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst